FdaApplication
ANDA 204074
Identifiers
- fda_app_no: ANDA204074
Properties
| Property | Value |
|---|---|
| applicant_name | CHARTWELL RX SCIENCES LLC |
| application_type | ANDA |
| approval_date | 2016-05-10 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAPSONE | DAPSONE | 100MG | TABLET;ORAL |
| DAPSONE | DAPSONE | 25MG | TABLET;ORAL |
2 products